Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating Brain Activity to Improve Cognitive-motor Function in Alzheimer's Disease

NCT04289402 is registered in ClinicalTrials.gov with Hebrew SeniorLife as lead sponsor.

NCT NCT04289402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04289402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating Brain Activity to Improve Cognitive-motor Function in Alzheimer's Disease
Lead sponsor
Hebrew SeniorLife
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2020
Completion date
December 31, 2027
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, alzheimer dementia, presenile alzheimer dementia